ClinicalTrials.Veeva

Menu

Pilot Prospective Study: Long-term Health of Living Kidney Donors

A

Amit Garg

Status

Completed

Conditions

Living Kidney Donors

Study type

Observational

Funder types

Other

Identifiers

NCT00319579
R-04-204
LKD Prospective Study

Details and patient eligibility

About

Kidney transplantation, a 'miracle' of modern medicine, is the preferred treatment option for End Stage Renal Disease compared to dialysis, patients who receive kidneys have a 70% reduction in risk of death, a dramatically improved quality of life and cost the health care system considerably less. As a result there are over 3000 Canadians, and 57,000 Americans on the waiting list for a kidney. To meet the shortage in cadaveric kidneys, rates of living kidney donation have nearly doubled over the last 10 years, and will continue to rise with growing demand.

Yet despite its advantages for the recipient, living kidney donation remains a complex ethical, moral and medical issue. The premise for accepting living donors is that the "minimal" risk of short and long-term medical harm realized by the donor is outweighed by the definite advantages to the recipient and potential psychosocial benefits of the altruistic gift to the donor. The only benefit for the living donor is psychological - donors experience increased self-esteem, feelings of well-being and improved health related quality of life with their altruistic act of assuming medical risk to help another. The short-term consequences of living donation are well established. On the other hand the long-term implications of living kidney donation are far less certain. This study will look at the long term implications of living kidney donation.

Enrollment

330 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age greater than 18 years old
  2. A predicted Cockcroft-Gault creatinine clearance > 80 mL/min
  3. Average sBP < 140 and dBP < 90 based on 3 readings
  4. A spot urine protein to creatinine ratio < 15 mg/mmol

Exclusion criteria

  1. A medical condition (such as cardiovascular disease, pulmonary disease, active cancer) or psychological condition (such as major affective disorder, personality disorder, a history of chemical dependence) which the local transplant centre deems unfit for donation. Blood group and immunological incompatibility (such as positive cross-match, poor HLA matches) are not reasons for exclusion
  2. Evidence of a financial incentive for donation
  3. A contraindication to general anaesthesia or surgery
  4. A past medical history of hypertension
  5. Use of antihypertensive class medications for any reason.(ACE-Is, ARBs, diuretics, beta-blockers, calcium channel blockers)
  6. A past history of permanent proteinuria
  7. The eligible non-donor is planning to donate their kidney within the next year
  8. Unable to give informed consent
  9. Unwilling to participate in the follow-up assessments at one, two, three, four and five years, or unwilling or unable to conduct home blood pressure or laboratory measurements
  10. The living donor or eligible non-donor is currently pregnant
  11. Despite being planned the donor nephrectomy does not take place
  12. Enrolled in another clinical study which interferes with the conduct or outcomes of this study

Trial design

330 participants in 1 patient group

Observation
Description:
Living Kidney Donors with controls who have not donated a kidney and meet certain criteria at the time of the donor's donation (i.e. no hypertension, no kidney disease, etc.).

Trial contacts and locations

15

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems